Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients (Q43896562)
Jump to navigation
Jump to search
scientific article published on 14 February 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients |
scientific article published on 14 February 2002 |
Statements
1 reference
Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients (English)
1 reference
1 reference
Dale Kempf
1 reference
Steven G Deeks
1 reference
Joseph J Eron
1 reference
Paul E Sax
1 reference
Constance A Benson
1 reference
Scott C Brun
1 reference
Roy M Gulick
1 reference
Harold A Kessler
1 reference
Charles Hicks
1 reference
Martin King
1 reference
David Wheeler
1 reference
Judith Feinberg
1 reference
Richard Stryker
1 reference
Sharon Riddler
1 reference
Melanie Thompson
1 reference
Kathryn Real
1 reference
Ann Hsu
1 reference
Anthony J Japour
1 reference
Eugene Sun
1 reference
14 February 2002
1 reference
1 reference
Identifiers
1 reference